Search results for: 'learning experience platform'

02 Feb 2021  |  Global  |  Megatrends

Future of Connected Living

The Top 3 Connectivity Ecosystems that will Simplify Human Lives—Homes, Cities, and Workplaces

Infographics

×

Key Issues Addressed

With more than 20 connected devices per human by 2030, we are rapidly moving to an environment that is permanently online and always connected. An increasingly digitalized and connected world will have a profound impact on a wide range of applications at home, at work, across cities, and several other use-cases (healthcare and automotive, for examp...

07 Apr 2022  |  Asia Pacific  |  Market Research

Southeast Asia Remote Building Security Solutions Growth Opportunities

Increasing Digitalization is Bolstering the Transformational Growth of the Industry in the Post-pandemic Era

Infographics

×

The remote building security solutions market in Southeast Asia is currently nascent. However, the COVID-19 pandemic has accelerated the need for remote monitoring solutions, boosting demand in this market. This demand, along with increasing manpower costs, favorable regulations in certain regions, and a shortage of skilled security forces, will he...

15 Jun 2022  |  North America  |  Market Research

US Automotive In-vehicle Navigation Growth Opportunities

Augmented Reality, Sensors, Connected Data, and AI Set to Transform Navigation Services for Users and Businesses

Infographics

×

The US automotive in-vehicle navigation market is converging. Numerous technological developments, such as cloud computing and AI/ML capabilities, have created numerous new use cases. These opportunities include the integration of augmented reality in head-up display (AR HUD), HD mapping and sensor analysis for ADAS, and personalized services to el...

Artificial intelligence (AI) is emerging as a transformative megatrend with the potential to reshape industries of the future. AI is poised to drive unprecedented changes that redefine how businesses create and deliver value, including revolutionizing customer experience (CX), operational efficiency, and IT operations. Its profound impact on compan...

06 Jul 2023  |  Global  |  Market Research

Global BIM and Digital Twin for Built Environment Growth Opportunities

The Dynamic Duo will Transform the Future of Digital Building Life Cycle Management

Infographics

×

Key Issues Addressed

BIM and digital twin are complementary technologies transforming the AEC industry by enabling collaborative design, improving project efficiency, and enhancing asset performance. BIM provides a comprehensive 3D modeling and data management platform, while digital twin extends it with data integration, optimization, simulation, and 3D virtual experi...

This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely used in radiology- and pathology-based diagnostics, its adoption is gradually increasing in...

This edition of the Cyber Security Technology Opportunity Engine (TOE) highlights key developments in cybersecurity technologies focusing on automated identity verification and AI-driven security solutions. Featured innovations include biometric authentication systems for digital onboarding, AI-powered detection posture management, cloud-native app...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...